Advanced search×

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Ann Intern Med 155(11):762-71 (2011) PMID 21984740

Screening can detect prostate cancer at earlier, asymptomatic stages, when treatments might be more effective.

DOI: 10.1059/0003-4819-155-11-201112060-00375
Version: za2963e q8zad q8zb5 q8zc8 q8zd7 q8zec q8zf2 q8zg8

Similar articles you may find interesting…

  1. Factors associated with readmission following plastic surgery- a review of 10,669 procedures from 2011 American College of Surgeons Nation S...

    Plast Reconstr Surg (2013) PMID 23676965

    : A total of 10,669 patients were included with a 4.5% readmission rate. The study cohort was on average 49.5 years of age, 32.2% were obese, and 15.2% were smokers. The majority of patients were female (81.7%). Cases were predominantly outpatient procedures (65.6%). The most commonly performed proce...
  2. PSA Screening and Deaths From Prostate Cancer After Diagnosis-A Population Based Analysis.

    Prostate (2013) PMID 23649537

    All analyses showed a 1991-1993 joinpoint, consistent with an impact of PSA screening. Between 1991 and 1999, incidence based mortality rates showed a decline for Whites of 10.9% (CI 9.2%-12.7%) and for Blacks of 11.6% (CI 9.7%-13.4%); incidence based mortality and D2 spread rate curves were similar...
  3. A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation.

    Bone Marrow Transplant (2013) PMID 23645166

    Evidence is mixed regarding the effects of hematopoietic cell transplantation (HCT) on changes in cognitive functioning among adults. Meta-analysis, which is designed to help reconcile conflicting findings, has not yet been conducted on studies of adults receiving HCT. To fill this g...